About this trial
This study will investigate the impact of combining dexamethasone and bispectral index (BIS) monitoring on the incidence of postoperative nausea and vomiting, emergence delirium and recovery trajectories in children undergoing ear-nose-throat (ENT) surgery.
Eligibility criteria
Qualifiers
children aged 2 to 8 years undergoing endoscopic adenoidectomy
parental/child consent
ASA I-II (American Society of Anaesthesiologists Physical Status)
no central nervous system (CNS) or gastrointestinal tract (GIT) disease
Disqualifiers
Parent/child disapproval
ASA III and above (American Society of Anaesthesiologists Physical Status)
central nervous system (CNS) or gastrointestinal tract (GIT) disease
chronic corticosteroid therapy
Trial design
Treatments tested in this trial
- BIS monitoring
- Sham BIS monitoring
Treatment groups
Sponsors and collaborators
University Hospital Ostrava
Lead sponsor
Municipal Hospital Ostrava
Collaborator
Havířov Hospital
Collaborator
Frýdek-Místek Hospital
Collaborator
Tomas Bata Hospital, Czech Republic
Collaborator